Motion und Emotion: Morbus Parkinson und Depression
Publisher
Springer-Verlag
Reference68 articles.
1. Alexopoulos GS (2001) »The depression-executive dysfunction syndrome of late life«: a specific target for D3 agonists? Am J Geriatr Psychiatry 9: 22–29
2. Allain H, Schuck S, Mauduit N (2000) Depression in Parkinson’s disease. BMJ 320: 1287–1288
3. Andersen J, Aabro E, Gulmann N, Hjelmsted A, Pedersen HE (1980) Anti-depressive treatment in Parkinson’s disease. A controlled trial of the effect of nortriptyline in patients with Parkinson’s disease treated with L-DOPA. Acta Neurol Scand 62: 210–219
4. Bauer M, Helmchen H (2000) Allgemeine Behandlungsprinzipien bei depressiven und manischen Störungen. In: Helmchen H, Henn F, Lauter H, Satorius N (Hrsg) Psychiatrie der Gegenwart. Springer, Berlin Heidelberg New York, S 475–493
5. Becker T, Becker G, Seufert J, Hofmann E, Lange KW, Naumann M, Lindner A, Reichmann H, Riederer P, Beckmann H, Reiners K (1997) Parkinson’s disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography. J Neurol Neurosurg Psychiatry 63: 590–596